-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2019 to Q3 2024.
- InMed Pharmaceuticals Inc. Depreciation, Depletion and Amortization for the quarter ending September 30, 2024 was $54.6K, a 0.46% decline year-over-year.
- InMed Pharmaceuticals Inc. annual Depreciation, Depletion and Amortization for 2024 was $220K, a 8.58% increase from 2023.
- InMed Pharmaceuticals Inc. annual Depreciation, Depletion and Amortization for 2023 was $202K, a 8.94% increase from 2022.
- InMed Pharmaceuticals Inc. annual Depreciation, Depletion and Amortization for 2022 was $186K, a 53.6% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)